Department of Dermatology, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Department of Medical Mycology, Institute of Dermatology and Hospital for Skin Diseases, Chinese Academy of Medical Science & Peking Union Medical College, Nanjing, China.
Mycoses. 2023 May;66(5):448-454. doi: 10.1111/myc.13571. Epub 2023 Feb 3.
Onychomycosis was an ignored disease in children, and the prevalence was still unknown worldwide.
This study was conducted to investigate the prevalence and treatment regimens of onychomycosis in children younger than 18 years old.
We systemically reviewed all publications by searching the key terms to reveal the onychomycosis in children from 1990 to 2022.
A total of 44 articles including 2,382 children with onychomycosis were enrolled in this study. The male to female ratio was 1.29:1. The youngest child was 35 days old and the average age was 9.8 years old. The duration of disease usually ranged from 7 days to 4 years. Onychomycosis in children was more prevalent in toenails compared to fingernails (77.6% vs. 18.4%), and 4% patients had both. A total of 527 children (22.12%) had concomitant tinea pedis infection, and in 267 patients (11.21%), their family members had onychomycosis or tinea pedis. The most common clinical type of onychomycosis was DLSO (67.74%) and the predominant isolates were T. rubrum (66.13%), followed by C. albicans (9.08%) and T. mentagrophytes complex (5.34%). There were 419 children (74.03%) receiving systematic treatment only, 74 patients (13.07%) receiving topical treatment only, and 73 patients (12.90%) receiving both systematic and topical treatment. Twelve patients (2.12%) had mild drug-related side effects. During the follow-up, 71.25% children were cured, 17.50% symptoms improved and 4.17% failed.
Onychomycosis was underestimated in children and the diagnosis of onychomycosis should be properly considered in children with nail disorders. For mild patients, topical treatment can be a good choice, and oral antifungal drugs could be added to severe individuals under monitoring.
儿童甲真菌病常被忽视,其全球流行情况尚不清楚。
本研究旨在调查年龄小于 18 岁的儿童甲真菌病的患病率和治疗方案。
通过检索关键词,系统回顾了 1990 年至 2022 年期间发表的所有关于儿童甲真菌病的文献。
本研究共纳入 44 篇文献,包含 2382 例儿童甲真菌病患者。男女性别比为 1.29:1。最小患儿年龄为 35 天,平均年龄为 9.8 岁。疾病病程通常为 7 天至 4 年。儿童甲真菌病更常见于趾甲,而不是指甲(77.6% vs. 18.4%),4%的患者同时累及两者。527 例(22.12%)患儿合并足癣感染,267 例(11.21%)患儿的家庭成员患有甲真菌病或足癣。最常见的临床甲真菌病类型是远端侧位甲下甲真菌病(DLSO)(67.74%),最主要的病原体是红色毛癣菌(66.13%),其次是白色念珠菌(9.08%)和须癣毛癣菌复合群(5.34%)。419 例(74.03%)患儿仅接受系统治疗,74 例(13.07%)仅接受局部治疗,73 例(12.90%)同时接受系统和局部治疗。12 例(2.12%)患儿出现轻度药物相关不良反应。随访期间,71.25%的患儿治愈,17.50%的患儿症状改善,4.17%的患儿治疗失败。
儿童甲真菌病常被低估,对于有甲损害的儿童,应适当考虑甲真菌病的诊断。对于轻度患者,局部治疗可能是一个不错的选择,对于严重患者,在监测下可加用口服抗真菌药物。